Precision BioSciences financial statements
프리시전 바이오사이언시스NASDAQ:DTIL · Nasdaq · Healthcare · sector #17$6.20-1.74%
2026-10-06 closePrecision BioSciences's published financial data is dated 2026-10-04. 2024 revenue was $69M. 2024 operating profit was −$26M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy